At a glance
ClinicalIndex Comparison RecordN/ACompleted· 77 enrolled
Drug / intervention
MARVEL 2 Algorithm Monitor Mode then Adaptive Modedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Micra Atrial TRacking Using A Ventricular AccELerometer 2
In Brief
A clinical study evaluating MARVEL 2 Algorithm Monitor Mode then Adaptive Mode for Atrioventricular Conduction Block. Completed, enrolled 77 participants across 12 sites in 8 countries.
Detailed Summary
The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacing in patients with normal sinus node function and AV block
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrioventricular Conduction Block
CountriesAustria, Belgium, Denmark, France, Hong Kong, Malaysia, Spain, United States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartJan 2019
Primary CompletionAug 2019
TodayJul 2026
First PostedNov 23, 2018
Enrollment StartJan 22, 2019
Primary CompletionAug 7, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.6 years ago
Interventions
MARVEL 2 Algorithm Monitor Mode then Adaptive Modedevice
Software download into implanted Micra device and programmed to MARVEL 2 Monitor Mode then MARVEL 2 Adaptive Mode